tirzepatide court ruling Compounding pharmacies can resume making as FDA reconsiders shortage Is Tirzepatide Legal in 2026?

However, some alleged long-term injuries for those using tirzepatide involve health outcomes not listed on the labels

This range is easy to measure with standard insulin syringes and comfortable to inject

SURMOUNT-4 (maintenance): after 36 weeks of open-label titration to a maximum-tolerated dose (10 or 15 mg), patients continuing that dose lost an additional 5.5% over 52 weeks

The FDA has ruled the shortage of these brand name medications has been resolved effective 05/22/2025

GLP-1 receptor agonists and risk for cirrhosis and related complications in patients with metabolic dysfunction-associated steatotic liver disease